Sponsor or institution
Clinical trials and research at Trellis Bioscience, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $3.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Bacterial Biofilm Therapy with a Human Antibody to Help Antibiotics Work Better
A human antibody drug is being studied to disrupt bacterial biofilms and help standard antibiotics clear infections, especially around implants and catheters, in adults.
-
Antibody therapy targeting RSV's G protein to treat acute infection in children
A patient-friendly immune therapy using a human monoclonal antibody (TRL3D3) aimed at treating RSV infection in young children by blocking the virus’s G protein.
-
New antibody treatment for bacterial pneumonia
This study is testing a new treatment called TRL1068 to see if it can help people with prosthetic joint infections by breaking down tough bacteria that resist antibiotics, making the antibiotics work better.
-
Investigating a new antibody treatment for HCMV infections
This study is testing a new treatment called TRL345, a special antibody that aims to help people, especially newborns and organ transplant patients, by fighting off infections from a virus called cytomegalovirus (HCMV) while keeping side effects low.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.